Millennium Management’s Fennec Pharmaceuticals FENC Stock Holding History

Millennium Management’s Portfolio FENC Stock Details FENC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$283K	Buy	+26,317	New	+$215K	﹤0.01%	5144
2026 Q1	–	Sell	-24,402	Closed	-$188K	–	5912
2025 Q4	$188K	Buy	24,402 +12,325	+102%	+$101K	﹤0.01%	5489
2025 Q3	$113K	Sell	12,077 -4,257	-26%	-$36.9K	﹤0.01%	5676
2025 Q2	$136K	Buy	+16,334	New	+$112K	﹤0.01%	5470
2024 Q4	–	Sell	-14,249	Closed	-$71.2K	–	6099
2024 Q3	$71.2K	Sell	14,249 -55,085	-79%	-$319K	﹤0.01%	5644
2024 Q2	$424K	Buy	69,334 +10,800	+18%	+$89.7K	﹤0.01%	4697
2024 Q1	$651K	Buy	58,534 +44,165	+307%	+$443K	﹤0.01%	4627
2023 Q4	$161K	Buy	+14,369	New	+$119K	﹤0.01%	5234
2023 Q3	–	Sell	-86,794	Closed	-$766K	–	6253
2023 Q2	$766K	Sell	86,794 -103,204	-54%	-$858K	﹤0.01%	4234
2023 Q1	$1.58M	Buy	189,998 +62,709	+49%	+$582K	﹤0.01%	3659
2022 Q4	$1.22M	Sell	127,289 -122,048	-49%	-$1.08M	﹤0.01%	3962
2022 Q3	$2.02M	Buy	249,337 +11,945	+5%	+$82K	﹤0.01%	3732
2022 Q2	$1.34M	Sell	237,392 -15,287	-6%	-$88.7K	﹤0.01%	4102
2022 Q1	$1.42M	Sell	252,679 -4,938	-2%	-$24.9K	﹤0.01%	4184
2021 Q4	$1.13M	Sell	257,617 -4	-0%	-$30	﹤0.01%	4298
2021 Q3	$2.43M	Sell	257,621 -147,151	-36%	-$1.1M	﹤0.01%	3684
2021 Q2	$2.95M	Buy	+404,772	New	+$2.7M	﹤0.01%	3460
2020 Q2	–	Sell	-19,180	Closed	-$114K	–	4279
2020 Q1	$114K	Buy	+19,180	New	+$125K	﹤0.01%	3530
2019 Q3	–	Sell	-47,634	Closed	-$191K	–	4283
2019 Q2	$191K	Buy	+47,634	New	+$202K	﹤0.01%	3770
2018 Q2	–	Sell	-92,658	Closed	-$1.12M	–	3900
2018 Q1	$1.12M	Buy	+92,658	New	+$875K	﹤0.01%	2632

Other funds holding FENC

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

SCM

Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PCA

Prospect Capital Advisors Sausalito, California $220M AUM 60.48% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Millennium Management's FENC Position: Q2 2026 in Review

Millennium Management opened a new position in Fennec Pharmaceuticals (FENC) in Q2 2026: 26,317 shares worth $283K. The stake represents ﹤0.01% of the portfolio and ranks #5144 among its holdings. This is a return to the name: Millennium Management previously reported a position in FENC as recently as Q4 2025.

Millennium Management first reported a position in FENC in Q1 2018 and has held it in 20 quarters since. The position peaked at $2.95M in Q2 2021. 105 funds tracked by Wall St. Rank hold FENC as of Q2 2026.

Millennium Management held 26,317 shares of Fennec Pharmaceuticals worth $283K as of Q2 2026.
Fennec Pharmaceuticals was a new Millennium Management position in Q2 2026.
Fennec Pharmaceuticals made up ﹤0.01% of Millennium Management's portfolio in Q2 2026, its #5144 holding.
Millennium Management first reported a position in Fennec Pharmaceuticals in Q1 2018 and has held it in 20 quarters since.
Millennium Management's Fennec Pharmaceuticals position peaked at $2.95M in Q2 2021.
105 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.